{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:13:32Z","timestamp":1766268812843,"version":"3.43.0"},"reference-count":24,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Spinal meningioma (SM) is a pathology with an estimated incidence of nearly 1000 diagnoses per year in the United States and presents in 20% of patients with neurofibromatosis type 2 (NF2). This multi-institutional retrospective cohort study aimed to assess clinical outcomes for patients with SM who underwent surgery between 1998 and 2020 with stratification by NF2 mutation status.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>Medical records were reviewed retrospectively to collect data on patient demographics, clinical presentation, tumor characteristics, treatment, and outcomes. Analyses were done to determine radiographic predictors of gross-total resection (GTR) and tumor recurrence, to assess radiographic characteristics of NF2-associated tumors, and to determine progression-free survival between groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>A total of 166 patients who received surgery for SM during the study period were included, of whom 133 were women (80%). Fifteen (9%) patients had a concurrent NF2 diagnosis. The mean age at surgery was 58 (SD 18) years. The mean presenting Karnofsky Performance Status score was 76 (SD 11), and the most common presenting symptoms were sensation changes (60%) and weakness (59%). Most tumors were in the thoracic spine (72%). GTR was achieved in 154 cases (93%). Eight patients with subtotal resection were treated with radiation therapy, and none received chemotherapy. Eighteen patients (11%) experienced radiographic recurrence of disease following surgery, with a mean time to recurrence of 4.2 years. NF2 patients were diagnosed at a significantly earlier mean age (33.3 [SD 15.4] years) compared with other patients. NF2 patients experienced progression at a significantly higher rate than other patients (40%), and in less time (mean 2.8 [SD 3.7] years). Radiographic characteristics, including tumor volume, T2 cord edema, dural tail sign, and calcification, were similar between NF2 and non-NF2 patients, between patients who underwent gross-total versus subtotal resection, and between patients who experienced tumor recurrence and those who did not.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>In this study of 166 surgically treated patients with SM, patients with NF2 presented earlier, experienced earlier progression, and experienced progression more frequently compared with those without NF2. Radiographic characteristics of tumors were relatively consistent between groups. While idiopathic SMs remain a relatively benign and highly manageable disease, considering tumor molecular characteristics and broader clinical history is paramount in providing efficacious and individualized patient care.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2024.7.spine24607","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T02:03:17Z","timestamp":1731722597000},"page":"1-10","source":"Crossref","is-referenced-by-count":3,"title":["Presenting characteristics and clinical outcomes of idiopathic versus neurofibromatosis type 2\u2013associated spinal meningiomas: a retrospective institutional experience"],"prefix":"10.3171","author":[{"given":"Noah L. A.","family":"Nawabi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts;"},{"name":"College of Medicine, Medical University of South Carolina, Charleston, South Carolina;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua I.","family":"Chalif","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Renauld","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts;"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neel H.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Jha","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob V. E.","family":"Gerstl","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Chalif","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saksham","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Chi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"17","key":"b1","series-title":"Cancer","first-page":"4220","article-title":"Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007","volume":"118","author":"Duong LM","year":"2012","unstructured":"Duong LM, McCarthy BJ, McLendon RE,  Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007. Cancer. 2012;118(17):4220\u20134227."},{"key":"b2","series-title":"Clin Neurol Neurosurg","first-page":"106238","article-title":"Spinal meningiomas: treatment outcome and long-term follow-up","volume":"198","author":"Kwee LE","year":"2020","unstructured":"Kwee LE, Harhangi BS, Ponne GA, Kros JM, Dirven CMF, Dammers R. Spinal meningiomas: treatment outcome and long-term follow-up. Clin Neurol Neurosurg. 2020;198:106238."},{"issue":"2","key":"b3","series-title":"Neurosurg Clin N Am","first-page":"195","article-title":"Management of spinal meningiomas","volume":"27","author":"Ravindra VM","year":"2016","unstructured":"Ravindra VM, Schmidt MH. Management of spinal meningiomas. Neurosurg Clin N Am. 2016;27(2):195\u2013205."},{"issue":"13","key":"b4","series-title":"Cancers (Basel)","first-page":"3244","article-title":"Long-term follow-up and predictors of functional outcome after surgery for spinal meningiomas: a population-based cohort study","volume":"13","author":"Pettersson-Segerlind J","year":"2021","unstructured":"Pettersson-Segerlind J, Fletcher-Sandersj\u00f6\u00f6 A, Tatter C,  Long-term follow-up and predictors of functional outcome after surgery for spinal meningiomas: a population-based cohort study. Cancers (Basel). 2021;13(13):3244."},{"issue":"1","key":"b5","series-title":"Sci Rep","first-page":"12563","article-title":"Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas","volume":"10","author":"Pemov A","year":"2020","unstructured":"Pemov A, Dewan R, Hansen NF,  Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas. Sci Rep. 2020;10(1):12563."},{"issue":"11","key":"b6","series-title":"Neuro Oncol","first-page":"1821","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","author":"Goldbrunner R","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD,  EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021;23(11):1821\u20131834."},{"issue":"6","key":"b7","series-title":"J Neurosurg","first-page":"804","article-title":"Spinal cord meningioma","volume":"57","author":"Levy WJ Jr","year":"1982","unstructured":"Levy WJ Jr, Bay J, Dohn D. Spinal cord meningioma. J Neurosurg. 1982;57(6):804\u2013812."},{"issue":"1","key":"b8","series-title":"J Neurosurg Sci","first-page":"7","article-title":"Spinal meningiomas: evaluation of 41 patients","volume":"49","author":"Peker S","year":"2005","unstructured":"Peker S, Cer\u00e7i A, Ozgen S, Isik N, Kalelioglu M, Pamir MN. Spinal meningiomas: evaluation of 41 patients. J Neurosurg Sci. 2005;49(1):7\u201311."},{"key":"b9","series-title":"Orphanet J Rare Dis","first-page":"16","article-title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review","volume":"4","author":"Evans DG","year":"2009","unstructured":"Evans DG. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis. 2009;4:16."},{"issue":"3","key":"b10","series-title":"J Neurosurg","first-page":"480","article-title":"Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2","volume":"99","author":"Otsuka G","year":"2003","unstructured":"Otsuka G, Saito K, Nagatani T, Yoshida J. Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2. J Neurosurg. 2003;99(3):480\u2013483."},{"issue":"6","key":"b11","series-title":"Asian Spine J","first-page":"865","article-title":"Epidemiology and survival after spinal meningioma surgery: a nationwide population-based study","volume":"16","author":"Jecko V","year":"2022","unstructured":"Jecko V, Weller J, Houston D, Champeaux-Depond C. Epidemiology and survival after spinal meningioma surgery: a nationwide population-based study. Asian Spine J. 2022;16(6):865\u2013873."},{"key":"b12","series-title":"J Neurosurg","first-page":"652","article-title":"Late recurrence of spinal-cord meningioma","volume":"19","author":"Feiring EH","year":"1962","unstructured":"Feiring EH, Barron K. Late recurrence of spinal-cord meningioma. J Neurosurg. 1962;19:652\u2013656."},{"issue":"2","key":"b13","series-title":"Neurosurgery","first-page":"153","article-title":"Spinal meningiomas: review of 174 operated cases","volume":"25","author":"Solero CL","year":"1989","unstructured":"Solero CL, Fornari M, Giombini S,  Spinal meningiomas: review of 174 operated cases. Neurosurgery. 1989;25(2):153\u2013160."},{"issue":"5","key":"b14","series-title":"Br J Neurosurg","first-page":"569","article-title":"Recurrence of spinal meningiomas: analysis of the risk factors","volume":"34","author":"Maiuri F","year":"2020","unstructured":"Maiuri F, Del Basso De Caro M, de Divitiis O, Guadagno E, Mariniello G. Recurrence of spinal meningiomas: analysis of the risk factors. Br J Neurosurg. 2020;34(5):569\u2013574."},{"issue":"6","key":"b15","series-title":"Neurosurgery","first-page":"739","article-title":"Simpson grade I-III resection of spinal atypical (World Health Organization Grade II) meningiomas is associated with symptom resolution and low recurrence","volume":"76","author":"Sun SQ","year":"2015","unstructured":"Sun SQ, Cai C, Ravindra VM,  Simpson grade I-III resection of spinal atypical (World Health Organization Grade II) meningiomas is associated with symptom resolution and low recurrence. Neurosurgery. 2015;76(6):739\u2013746."},{"issue":"6","key":"b16","series-title":"Neurosurg Focus","first-page":"E2","article-title":"Spinal meningiomas: surgical management and outcome","volume":"14","author":"Gottfried ON","year":"2003","unstructured":"Gottfried ON, Gluf W, Quinones-Hinojosa A, Kan P, Schmidt MH. Spinal meningiomas: surgical management and outcome. Neurosurg Focus. 2003;14(6):E2."},{"issue":"2","key":"b17","series-title":"Indian J Radiol Imaging","first-page":"205","article-title":"A radiologists\u2019 guide to en bloc resection of primary tumors in the spine: what does the surgeon want to know?","volume":"32","author":"Smith E","year":"2022","unstructured":"Smith E, Hegde G, Czyz M,  A radiologists\u2019 guide to en bloc resection of primary tumors in the spine: what does the surgeon want to know? Indian J Radiol Imaging. 2022;32(2):205\u2013212."},{"issue":"3","key":"b18","series-title":"Nat Genet","first-page":"295","article-title":"Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas","volume":"45","author":"Smith MJ","year":"2013","unstructured":"Smith MJ, O\u2019Sullivan J, Bhaskar SS,  Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat Genet. 2013;45(3):295\u2013298."},{"issue":"1","key":"b19","series-title":"Clin Genet","first-page":"82","article-title":"Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma","volume":"81","author":"Zirn B","year":"2012","unstructured":"Zirn B, Arning L, Bartels I,  Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma. Clin Genet. 2012;81(1):82\u201387."},{"issue":"1","key":"b20","series-title":"J Neurooncol","first-page":"115","article-title":"Coexisting cranial and multiple spinal meningioma in a child-report of a case","volume":"102","author":"Shukla SK","year":"2011","unstructured":"Shukla SK, Trivedi A, Sharma V, Singh K. Coexisting cranial and multiple spinal meningioma in a child-report of a case. J Neurooncol. 2011;102(1):115\u2013119."},{"issue":"1","key":"b21","series-title":"Neurol Med Chir (Tokyo)","first-page":"12","article-title":"Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization","volume":"43","author":"Arslantas A","year":"2003","unstructured":"Arslantas A, Artan S, Oner U,  Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization. Neurol Med Chir (Tokyo). 2003;43(1):12\u201319."},{"issue":"5","key":"b22","series-title":"Acta Neuropathol","first-page":"1053","article-title":"Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord","volume":"144","author":"Hua L","year":"2022","unstructured":"Hua L, Alkhatib M, Podlesek D,  Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord. Acta Neuropathol. 2022;144(5):1053\u20131055."},{"issue":"5","key":"b23","series-title":"Neuro Oncol","first-page":"796","article-title":"A molecularly integrated grade for meningioma","volume":"24","author":"Driver J","year":"2022","unstructured":"Driver J, Hoffman SE, Tavakol S,  A molecularly integrated grade for meningioma. Neuro Oncol. 2022;24(5):796\u2013808."},{"issue":"6","key":"b24","series-title":"J Neurosurg Spine","first-page":"729","article-title":"Genomic analysis of spinal meningiomas: correlation with histopathological grade","volume":"39","author":"Driver J","year":"2023","unstructured":"Driver J, Santagata S, Bi WL, Chi JH. Genomic analysis of spinal meningiomas: correlation with histopathological grade. J Neurosurg Spine. 2023;39(6):729\u2013733."}],"container-title":["Journal of Neurosurgery: Spine"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/aop\/article-10.3171-2024.7.SPINE24607\/article-10.3171-2024.7.SPINE24607.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/aop\/article-10.3171-2024.7.SPINE24607\/article-10.3171-2024.7.SPINE24607.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/aop\/article-10.3171-2024.7.SPINE24607\/article-10.3171-2024.7.SPINE24607.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T01:57:01Z","timestamp":1738375021000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/aop\/article-10.3171-2024.7.SPINE24607\/article-10.3171-2024.7.SPINE24607.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":24,"URL":"https:\/\/doi.org\/10.3171\/2024.7.spine24607","relation":{},"ISSN":["1547-5654"],"issn-type":[{"type":"print","value":"1547-5654"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}